Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.